Utama › Leukemia Mieloid Akut › New York › Queens
Kajian klinikal Leukemia Mieloid Akut di Queens, NY
21 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Queens (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Queens Hospital Center, Jamaica · 2 mi jauh
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
A Study of CRD3874-SI in People With Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi jauh
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Mengambil pesertaFasa 3
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi jauh
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Mengambil pesertaFasa 2
- Clinical Research Allicance, Westbury · 14 mi jauh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Mengambil pesertaFasa 1/2
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi jauh
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 3
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Northwell Health, LLC PRIME, Lake Success · 9 mi jauh
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauh
A Study of Revumenib and Mezigdomide in People With Leukemia
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi jauh
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauh
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauh
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Mengambil pesertaFasa 2/3
- New York University Langone Hospital - Long Island, Mineola · 11 mi jauh
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi jauh
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Seattle, WA41 kajian
- Baldwin Park, CA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA31 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di Queens
- Kanser Payudara64 kajian
- Kanser Paru-paru Bukan Sel Kecil49 kajian
- Kanser Kolorektal31 kajian
- Kanser Metastatik28 kajian
- Kanser Ovari28 kajian
- Kanser Prostat27 kajian
- Kanser (semua jenis)26 kajian
- Kanser Endometrium25 kajian
- Kanser Paru-paru22 kajian
- Mieloma Pelbagai20 kajian
- Kanser Pankreas20 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.